Literature DB >> 11391015

Modeling multi-component protein-DNA complexes: the role of bending and dimerization in the complex of p53 dimers with DNA.

A Lebrun1, R Lavery, H Weinstein.   

Abstract

We used molecular modeling to study the optimal conformation of the complex between two p53 DNA-binding domain monomers and a 12 base-pair target DNA sequence. The complex was constructed using experimental data on the monomer binding conformation and a new approach to deform the target DNA sequence. Combined with an internal/helicoidal coordinate model of DNA, this approach enables us to bend the target sequence in a controlled way while respecting the contacts formed with each p53 monomer. The results show that the dimeric complex favors DNA bending towards the major groove at the dimer junction by a value close to experimental findings. In contrast to inferences from earlier models, the calculation of key contributions to the free energy of the complexes indicates a determinant role for DNA in the formation of the complex with the dimer of the p53 DNA-binding domains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391015     DOI: 10.1093/protein/14.4.233

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  5 in total

1.  Energetic and structural considerations for the mechanism of protein sliding along DNA in the nonspecific BamHI-DNA complex.

Authors:  Jian Sun; Hector Viadiu; Aneel K Aggarwal; Harel Weinstein
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

2.  Probing protein mechanics: residue-level properties and their use in defining domains.

Authors:  Isabelle Navizet; Fabien Cailliez; Richard Lavery
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

3.  Cooperative fluctuations point to the dimerization interface of p53 core domain.

Authors:  Nigar Kantarci; Pemra Doruker; Turkan Haliloglu
Journal:  Biophys J       Date:  2006-07-15       Impact factor: 4.033

4.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

5.  Core domain interactions in full-length p53 in solution.

Authors:  Dmitry B Veprintsev; Stefan M V Freund; Antonina Andreeva; Stacey E Rutledge; Henning Tidow; José Manuel Pérez Cañadillas; Caroline M Blair; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.